SG Americas Securities’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-34,888
Closed -$164K 3307
2023
Q2
$164K Buy
34,888
+8,568
+33% +$39.4K ﹤0.01% 1881
2023
Q1
$122K Buy
26,320
+3,197
+14% +$14.1K ﹤0.01% 2789
2022
Q4
$84K Sell
23,123
-5,257
-19% -$23.3K ﹤0.01% 2766
2022
Q3
$134K Buy
28,380
+10,288
+57% +$51.7K ﹤0.01% 2626
2022
Q2
$88K Buy
+18,092
New +$110K ﹤0.01% 3165

Other funds holding THRN

SG Americas Securities's THRN Position: Q3 2023 in Review

SG Americas Securities sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q3 2023, closing a stake of 34,888 shares — an estimated $164K sold.

SG Americas Securities first reported a position in THRN in Q2 2022 and held it in 5 quarters. The position peaked at $164K in Q2 2023. 59 funds tracked by Wall St. Rank hold THRN as of Q3 2023.

  • SG Americas Securities reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • SG Americas Securities sold 34,888 Thorne Healthtech, Inc. Common Stock shares in Q3 2023, an estimated $164K.
  • SG Americas Securities first reported a position in Thorne Healthtech, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • SG Americas Securities's Thorne Healthtech, Inc. Common Stock position peaked at $164K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q3 2023.

Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.